Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › DNA Medicine Institute Wins $1.5M NIH Grant to Develop Point-of-Care Factor VIII, Hemlibra Test

DNA Medicine Institute Wins $1.5M NIH Grant to Develop Point-of-Care Factor VIII, Hemlibra Test

Oct 12, 2020
|
staff reporter

NEW YORK — Medical technology incubator The DNA Medicine Institute last month was awarded a $1.5 million grant from the National Institutes of Health to develop a rapid, point-of-care fingerstick blood-based test for Factor VIII (FVIII) and Roche's hemophilia A treatment emicizumab (Hemlibra).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Point-of-Care Testing

  1. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  2. Maxim Biomedical Ramps Up Manufacturing, Completes Validation of 15-Minute SARS-CoV-2 Antigen Test

    Premium

  3. UK Researchers Seek to Commercialize 15-Minute, POC Test for Traumatic Brain Injury

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.